Hypoxia inducible factor-1α gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma

Journal of Surgical Oncology

Volumn 102, Issue 2, 2010, Pages 163-169

  Hsiao, Pei Ching ^a,b   Chen, Mu Kuan ^a,c,d   Su, Shih Chi ^e   Ueng, Kwo Chang ^a,b   Chen, Yi Chen ^a   Hsieh, Yi Hsien ^a   Liu, Yu Fan ^a   Tsai, Hsiu Ting ^a   Yang, Shun Fa ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d MINGDAO UNIVERSITY   (Taiwan)

^e TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Hepatocellular carcinoma; Hypoxia inducible factor 1 ; Polymorphism

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HETEROZYGOTE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TOBACCO;

ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SMOKING; TAIWAN;

EID: 77955116731     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21539     Document Type: Article

References (49)

1. Semenza GL, Rue EA, Iyer NV, et al.: Assignment of the hypoxiainducible factor 1alpha gene to a region of conserved synteny on mouse chromosome 12 and human chromosome 14q. Genomics 1996;34:437-439.
2. Wang GL, Jiang BH, Rue EA, et al.: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995;92:5510-5514.
3. Kimura H, Weisz A, Kurashima Y, et al.: Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 2000; 95:189-197.
4. Kimura H, Weisz A, Ogura T, et al.: Identification of hypoxiainducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem 2001;276:2292-2298.
5. Semenza GL: HIF-1, O(2), and the 3 PHDs: How animal cells signal hypoxia to the nucleus. Cell 2001;107:1-3.
6. Brennan PA, Umar T, Wilson AW, et al.: Expression of type 2 nitric oxide synthase and vascular endothelial growth factor in oral dysplasia. J Oral Maxillofac Surg 2002;60:1455-1460.
7. Brennan PA, Umar T, Smith GI, et al.: Expression of nitric oxide synthase-2 in cutaneous squamous cell carcinoma of the head and neck. Br J Oral Maxillofac Surg 2002;40:191-194. (Pubitemid 34760042)
8. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-732.
9. Huang LE, Bunn HF: Hypoxia-inducible factor and its biomedical relevance. J Biol Chem 2003;278:19575-19578.
10. Liu F, Wang P, Jiang X, et al.: Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma. Cancer Sci 2008;99:2055-2061.
11. Bosch FX, Ribes J, Cleries R, et al.: Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005;9:191-211.
12. Tilakaratne WM, Iqbal Z, Teh MT, et al.: Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis. J Oral Pathol Med 2008;37:372-377.
13. Department of Health Health statistics: II. Vital statistics. Taipei, China: Department of Health; 2007.
14. Tanimoto K, Yoshiga K, Eguchi H, et al.: Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 2003;24:1779-1783.
15. Liang X, Yang D, Hu J, et al.: Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma. Anticancer Res 2008;28:1659-1666. (Pubitemid 351892941)
16. Miyazaki Y, Hara A, Kato K, et al.: The effect of hypoxic microenvironment on matrix metalloproteinase expression in xenografts of human oral squamous cell carcinoma. Int J Oncol 2008;32:145-151.
17. Ishikawa T, Nakashiro K, Klosek SK, et al.: Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma. Oncol Rep 2009;21:707-712.
18. Lam W, Bussom S, Cheng YC: Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma. Mol Cancer Ther 2009;8:415-423.
19. Zhong H, De Marzo AM, Laughner E, et al.: Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999;59:5830-5835.
20. Burkitt K, Chun SY, Dang DT, et al.: Targeting both HIF-1 and HIF-2 in human colon cancer cells improves tumor response to sunitinib treatment. Mol Cancer Ther 2009; 1148-1156
21. Wang W, Xu GL, Jia WD, et al.: Expression and correlation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and microvessel density in experimental rat hepatocarcinogenesis. J Int Med Res 2009;37:417-425.
22. Sasabe E, Tatemoto Y, Li D, et al.: Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells. Cancer Sci 2005;96:394-402.
23. Huang GW, Yang LY, Lu WQ: Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival. World J Gastroenterol 2005;11:1705-1708. (Pubitemid 40520818)
24. Nakamura K, Zen Y, Sato Y, et al.: Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver. Hum Pathol 2007;38:1532-1546.
25. Daskalow K, Pfander D, Weichert W, et al.: Distinct temporospatial expression patterns of glycolysis-related proteins in human hepatocellular carcinoma. Histochem Cell Biol 2009;132: 21-31.
26. Lau CK, Yang ZF, Ho DW, et al.: An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells. Clin Cancer Res 2009;15:3462-3471.
27. Xie H, Song J, Liu K, et al.: The expression of hypoxia-inducible factor-1alpha in hepatitis B virus-related hepatocellular carcinoma: Correlation with patients' prognosis and hepatitis B virus X protein. Dig Dis Sci 2008;53:3225-3233.
28. Clifford SC, Astuti D, Hooper L, et al.: The pVHL-associated SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Oncogene 2001;20:5067-5074.
29. Fu XS, Choi E, Bubley GJ, et al.: Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate 2005;63:215-221.
30. Hebert C, Norris K, Parashar P, et al.: Hypoxia-inducible factor-1alpha polymorphisms and TSC1/2 mutations are complementary in head and neck cancers. Mol Cancer 2006;5:3.
31. Li K, Zhang Y, Dan Z, et al.: Association of the hypoxia inducible factor-1alpha gene polymorphisms with gastric cancer in Tibetans. Biochem Genet. 2009;47:625-634.
32. Muñoz-Guerra MF, Fernández-Contreras ME, Moreno AL, et al.: Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer. Ann Surg Oncol. 2009;16:2351-2358.
33. Chen MK, Chiou HL, Su SC, et al.: The association between hypoxia inducible factor-1alpha gene polymorphisms and increased susceptibility to oral cancer. Oral Oncol. 2009;45: e222-e226.
34. Fransen K, Fenech M, Fredrikson M, et al.: Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol Carcinog 2006;45: 833-840.
35. Ollerenshaw M, Page T, Hammonds J, et al.: Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype. Cancer Genet Cytogenet. 2004;153:122-126. (Pubitemid 39592144)
36. Centers for Disease Control, Taiwan. http://wwwcdcgovtw 2007.
37. Pang R, Poon RT: Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett 2006;242:151-167. (Pubitemid 44485315)
38. Yu MC, Yuan JM: Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004;127:S72-78.
39. El-Zayadi AR: Heavy smoking and liver. World J Gastroenterol 2006;12:6098-6101.
40. Hassan MM, Spitz MR, Thomas MB, et al.: Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int J Cancer 2008;123:1883-1891.
41. McKillop IH, Schrum LW: Role of alcohol in liver carcinogenesis. Semin Liver Dis 2009;29:222-232.
42. Schutte K, Bornschein J, Malfertheiner P: Hepatocellular carcinoma - epidemiological trends and risk factors. Dig Dis 2009;27:80-92.
43. Li L, Chen SH, Zhang Y, et al.: Is the hypoxia-inducible factor-1 alpha mRNA expression activated by ethanol-induced injury, the mechanism underlying alcoholic liver disease? Hepatobiliary Pancreat Dis Int 2006;5:560-563.
44. Lin PY, Yu CH, Wang JT, et al.: Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 2008;37:18-25.
45. Bailey SM, Mantena SK, Millender-Swain T, et al.: Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: Implications for a "multihit" hypothesis of fatty liver disease. Free Radic Biol Med 2009;46:928-938.
46. Yoo YG, Na TY, Seo HW, et al.: Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 2008;27:3405-3413.
47. Nasimuzzaman M, Waris G, Mikolon D, et al.: Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. J Virol 2007;81: 10249-10257.
48. Miyoshi A, Kitajima Y, Ide T, et al.: Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1alpha-independent manner. Int J Oncol 2006;29:1533-1539.
49. Mazure NM, Chauvet C, Bois-Joyeux B, et al.: Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: Characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc. Cancer Res 2002;62:1158-1165. (Pubitemid 34160303)